Aleteia logoAleteia logo
Monday 26 July |
Saint of the Day: Sts Joachim and Anne
home iconNews
line break icon

“Young blood” may help those with Alzheimer’s disease



J-P Mauro - published on 11/07/17 - updated on 11/07/17

New research indicates that young human blood plasma may have rejuvenating effects.

Researchers from Stanford University have found that the infusion of plasma from the blood of young people may be beneficial for Alzheimer’s patients. They first became aware of this possibility after the publication of another study from Stanford, earlier this year, in which researchers injected older mice with young human blood plasma and saw rejuvenating effects.

This new, admittedly limited, study focused on 18 Alzheimer’s patients who received a plasma infusion from healthy young men. While the treatment did seem to perk some of them up, it did not have an effect on memory or thinking skills.

NBC news has the details of the research:

At first they did what’s called a blinded trial — treating half the patients with real plasma, and giving half the patients a sham infusion, with no one knowing which patient got the real treatment. Then they swapped the two sides. Later, because it was taking so much time and effort, they cut the trial to just nine people and all nine knew they were getting the real thing – a unit of plasma, once a week for a month, from healthy young men under the age of 30. There was no measurable effect on memory or thinking, the team told the Clinical Trials on Alzheimer’s Disease conference in Boston. But researcher, Dr. Sharon Sha, said on two measurements of function there was a difference in answers the caregivers gave on a questionnaire.

Dr. Sha, a researcher on the team, notes that while caregivers have noticed an increase in attention span and conversation participation, there is no indication that the therapy will reverse memory loss. She cautions patients from rushing into treatment before their study is complete.

“I worry that people would take this information and say, ‘I need to get this. I need to get young blood.’ It’s important to understand the science behind this first,” Sha said

Joe McCracken, vice president for development at Alkahest, the medical company which will be working to create a marketable treatment using young human plasma, is hopeful that this research may be applied in the near future. Alkahest will begin formal clinical trials with 40 patients next year.

Support Aleteia!

If you’re reading this article, it’s thanks to the generosity of people like you, who have made Aleteia possible.

Here are some numbers:

  • 20 million users around the world read every month
  • Aleteia is published every day in seven languages: English, French, Italian, Spanish, Portuguese, Polish, and Slovenian
  • Each month, readers view more than 50 million pages
  • Nearly 4 million people follow Aleteia on social media
  • Each month, we publish 2,450 articles and around 40 videos
  • We have 60 full time staff and approximately 400 collaborators (writers, translators, photographers, etc.)

As you can imagine, these numbers represent a lot of work. We need you.

Support Aleteia with as little as $1. It only takes a minute. Thank you!

Daily prayer
And today we celebrate...

Top 10
Philip Kosloski
This morning prayer is easy to memorize
Daniel Esparza
5 Curious things you might not know about Catholicism
Joachim and Anne
Philip Kosloski
Did Jesus know his grandparents?
J-P Mauro
Reconstructing a 12th-century pipe organ discovered in the Holy L...
Philip Kosloski
This prayer to St. Anthony is said to have “never been know...
Cerith Gardiner
5 Ways grandparents impact our lives for the better
Cecilia Pigg
Simplify your life and honor your body with these 5 natural perso...
See More
Get Aleteia delivered to your inbox. Subscribe here.